Cronos Group Stock News

Equities researchers at Bank of America started coverage on shares of Cronos Group (NASDAQ:CRON) in a note issued to investors on Thursday. The firm set an underperform rating and a $5.00 price target on the stock. Bank of Americas price target would indicate a potential upside of 0.60% from the stocks previous close. Other research []

Bank of America started coverage on shares of Cronos Group (NASDAQ:CRON) in a research note issued on Thursday. The brokerage set an underperform rating and a $5.00 price target on the stock. Bank of Americas price target suggests a potential upside of 0.60% from the companys current price. Several other research firms also recently commented []

Investment analysts at Barclays began coverage on shares of Cronos Group (TSE:CRON) in a note issued to investors on Thursday, TipRanks reports. The firm set a sell rating and a C$5.50 price target on the stock. Barclayss price target suggests a potential downside of 12.00% from the companys current price. CRON has been the subject []

An analyst initiated coverage on three of the stocks, but all of them fell as a result.

Senator Schumer's "big boys" comment causes big losses for cannabis stocks.

Cannabis company Cronos Group Inc. (NASDAQ:CRON)  announced last week that it had to delay filing third-quarter earnings due to pending impairment charges for its U.S. CBD activities.  The Toron

Meet Cron, a new calendar app for the Mac that wants to bring some innovation to this space. The startup directly mentions Sunrise as an inspiration for those of you who still remember it.

By running a validator node with Bison Trails, Particle B aims to support and enhance the security of Cronos mainnet beta. Continue reading Particle B Enlists Bison Trails to Run a Validator Node for the Cronos Testnet and Mainnet Beta at DailyCoin.com.

NEW YORK, Nov. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, NAKD, CLOV, QS, and CRON. Full story available on Benzinga.com

Cronos Group (NASDAQ:CRON) and Bon Natural Life (NYSE:BON) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Institutional and Insider Ownership 13.8% of Cronos Group shares are held by institutional investors. Comparatively, […]

Cronos Group Inc. (NASDAQ:CRON) shares saw unusually-high trading volume on Monday . Approximately 267,921 shares traded hands during trading, a decline of 92% from the previous sessions volume of 3,551,037 shares.The stock last traded at $6.02 and had previously closed at $6.26. CRON has been the subject of several analyst reports. Zacks Investment Research cut []

Shares of Cronos Group Inc. (NASDAQ:CRON) shot up 8.6% during trading on Friday . The stock traded as high as $6.17 and last traded at $6.17. 331,253 shares were traded during trading, a decline of 91% from the average session volume of 3,544,434 shares. The stock had previously closed at $5.68. Several brokerages have recently []

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to sha

Cronos Group Inc (NASDAQ: CRON) remains in the focus of investors after New Cannabis Ventures reported that the Altria Group Inc (NYSE: MO) could buy the remaining outstanding shares of the cannabis c

The Canadian marijuana company no longer has confidence in its U.S. CBD assets.